IL-18/IGIF chemotherapeutic compositions
US6582689B1 · kind B1 · utility
5Cited by
3References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 17, 2000 |
| Grant date | Jun 24, 2003 |
| Priority date | — |
| Expiry date | Nov 17, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to compositions comprising potentiators, such as IL-18, also known as interferon-&ggr;-inducing factor (IGIF), in combination with a chemotherapeutic agent, processes for making such compositions, the use of such compositions for the prevention and/or treatment of cancer, and the use of such compositions to inhibit the growth of tumors or cancerous cells in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.